In particular, we observed a preferential enrichment of CD8+ T cells expressing PD‐1 and Trm markers in intermediate and marginal tumor areas, in which glioblastoma cells showed an active 5‐ALA metabolism. This evidence concerns the gene CD8A and neoplasm.